Construction of a Novel LncRNA Signature Related to Genomic Instability to Predict the Prognosis and Immune Activity of Patients With Hepatocellular Carcinoma

Abstract

BackgroundGenomic instability (GI) plays a crucial role in the development of various cancers including hepatocellular carcinoma. Hence, it is meaningful for us to use long non-coding RNAs related to genomic instability to construct a prognostic signature for patients with HCC.MethodsCombining the lncRNA expression profiles and somatic mutation profiles in The Cancer Genome Atlas database, we identified GI-related lncRNAs (GILncRNAs) and obtained the prognosis-related GILncRNAs through univariate regression analysis. These lncRNAs obtained risk coefficients through multivariate regression analysis for constructing GI-associated lncRNA signature (GILncSig). ROC curves were used to evaluate signature performance. The International Cancer Genomics Consortium (ICGC) cohort, and in vitro experiments were used for signature external validation. Immunotherapy efficacy, tumor microenvironments, the half-maximal inhibitory concentration (IC50), and immune infiltration were compared between the high- and low-risk groups with TIDE, ESTIMATE, pRRophetic, and ssGSEA program.ResultsFive GILncRNAs were used to construct a GILncSig. It was confirmed that the GILncSig has good prognostic evaluation performance for patients with HCC by drawing a time-dependent ROC curve. Patients were divided into high- and low-risk groups according to the GILncSig risk score. The prognosis of the low-risk group was significantly better than that of the high-risk group. Independent prognostic analysis showed that the GILncSig could independently predict the prognosis of patients with HCC. In addition, the GILncSig was correlated with the mutation rate of the HCC genome, indicating that it has the potential to measure the degree of genome instability. In GILncSig, LUCAT1 with the highest risk factor was further validated as a risk factor for HCC in vitro. The ESTIMATE analysis showed a significant difference in stromal scores and ESTIMATE scores between the two groups. Multiple immune checkpoints had higher expression levels in the high-risk group. The ssGSEA results showed higher levels of tumor-antagonizing immune cells in the low-risk group compared with the high-risk group. Finally, the GILncSig score was associated with chemotherapeutic drug sensitivity and immunotherapy efficacy of patients with HCC.ConclusionOur research indicates that GILncSig can be used for prognostic evaluation of patients with HCC and provide new insights for clinical decision-making and potential therapeutic strategies.

FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expression

“…RNA-seq data (level 3) and corresponding clinical information of 178 pancreatic cancer samples were obtained from TCGA database ( https://portal.gdc.cancer.gov/ ). The gene set [ 63 ] contained in the relevant pathway was analyzed using the GSVA package, with the parameter method = ‘ssgsea.’ The enrichment score of each sample on each pathway was calculated according to the ssGSEA algorithm [ 64 ] to obtain the sample, and the connection between the pathways. Finally, the correlation between FAT10 expression and EMT pathway score was analyzed by Spearman correlation.…”

Long non-coding RNA signature for predicting gastric cancer survival based on genomic instability

“…Zhu et al constructed lncRNA signature with genomic instability to assess the prognosis and immune activity of patients with hepatocellular carcinoma (HCC). They found that the prognosis of high-risk patients was significantly worse, and the genomic instability score was related to chemotherapy drug sensitivity and immunotherapy effect of HCC patients [ 41 ]. Yang et al also constructed a signature composed of five lncrnas to assess the prognosis and immune characteristics of patients with pancreatic ductal adenocarcinoma.…”

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma

“…Similarly, the ssGSEA results indicated that the infiltration rate of most immune cells in the high-risk group was lower than in the low-risk group. Some of them were reported to be tumor antagonistic immune cells ( 32 , 33 ). In a previous study, the infiltration of activated CD8 T cells was proven to correlate to improved prognosis and survival of primary ovarian cancer ( 34 ).…”